Recent advances in Hepatitis E Virus
Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland
Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance
Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy
Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders
Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection
Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis
Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*
Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome
T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV–HCV co-infected patients
In vivo effects of fluvastatin on HCV replication in HIV-1 coinfected subjects